Study Examines Cerebrospinal Fluid Diffusion Of Bictegravir/Emtricitabine/Tenofovir In HIV-Related Central Nervous System Impairment

October 08, 2021

Infectious Disease Advisor (10/7, Gupta) reports, “Among patients younger than 51 years of age with HIV-related central nervous system impairment (HCI), first-line treatment with an antiretroviral (ART) regimen of bictegravir, emtricitabine, and tenofovir...